Equities

Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,388.70
  • Today's Change-30.15 / -2.12%
  • Shares traded17.10k
  • 1 Year change+138.06%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 10:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2021202120202019
OPERATIONS
Net income1407783
Depreciation/depletion251912
Non-Cash items131611
Cash taxes paid, supplemental382025
Cash interest paid, supplemental13196.18
Changes in working capital(2.16)4.55(94)
Total cash from operations17511713
INVESTING
Capital expenditures(88)(60)(108)
Other investing and cash flow items, total3.6400
Total cash from investing(85)(60)(108)
FINANCING
Financing cash flow items(13)(19)(6.18)
Total cash dividends paid------
Issuance (retirement) of stock, net1.9000
Issuance (retirement) of debt, net(4.28)(32)78
Total cash from financing(15)(50)72
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash757.30(23)
Net cash-begin balance/reserved for future use147.0730
Net cash-end balance/reserved for future use90147.07
SUPPLEMENTAL INCOME
Depreciation, supplemental251912
Cash interest paid, supplemental13196.18
Cash taxes paid, supplemental382025
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.